中国神经精神疾病杂志
中國神經精神疾病雜誌
중국신경정신질병잡지
CHINESE JOURNAL OF NERVOUS AND MENTAL DISEASES
2014年
2期
97-101
,共5页
李双%刘长江%周蓦%龙振海%王萍%齐萍%张屏%孙秀艳%周硕%佟伟军
李雙%劉長江%週驀%龍振海%王萍%齊萍%張屏%孫秀豔%週碩%佟偉軍
리쌍%류장강%주맥%룡진해%왕평%제평%장병%손수염%주석%동위군
胆红素%急性缺血性脑卒中%残疾%死亡%复合结局%预后
膽紅素%急性缺血性腦卒中%殘疾%死亡%複閤結跼%預後
담홍소%급성결혈성뇌졸중%잔질%사망%복합결국%예후
Bilirubin%Acute ischemic stroke%Disability death%Composite outcome%Prognosis
目的:探讨入院时胆红素水平与急性缺血性脑卒中患者出院复合结局(残疾或死亡)的关联。方法采用回顾性队列研究的方法,连续性纳入2009年6月1日至2012年5月31日阜新市中心医院神经内科3151例住院的急性缺血性脑卒中患者,收集人口统计学、生活方式、临床表现和实验室检验资料。出院时应用改良Rankin量表(modified Rankin scale,mRS)评分,mRS≥3分为残疾,mRS≥3或死亡为复合结局。根据入院时总胆红素、间接胆红素、直接胆红素的四分位数水平分别将研究对象分为4组,采用Cox回归分析入院时胆红素水平与急性缺血性脑卒中患者出院残疾、死亡和复合结局的关联。结果发生残疾的病例为407例,残疾发生率为12.9%,死亡104例,病死率为3.3%。经多因素调整后,发现以总胆红素第1分位数组为参比,第4分位数组发生复合结局的aHR值(95%CI)为1.335(1.047~1.702);以间接胆红素第1分位数组为参比,第4分位数组发生复合结局的aHR值(95%CI)为1.355(1.062~1.728);以直接胆红素第1分位数组为参比,第3、4分位数组发生复合结局的aHR值(95%CI)分别为1.403(1.089~1.807)、1.431(1.118~1.833);并且随着总胆红素、间接胆红素和直接胆红素水平的升高,出院复合结局的发生风险也在增加(P<0.05)。结论入院时胆红素水平的升高可增加急性缺血性脑卒中患者出院复合结局的风险、并且存在着剂量反应关系,是独立的危险因素。
目的:探討入院時膽紅素水平與急性缺血性腦卒中患者齣院複閤結跼(殘疾或死亡)的關聯。方法採用迴顧性隊列研究的方法,連續性納入2009年6月1日至2012年5月31日阜新市中心醫院神經內科3151例住院的急性缺血性腦卒中患者,收集人口統計學、生活方式、臨床錶現和實驗室檢驗資料。齣院時應用改良Rankin量錶(modified Rankin scale,mRS)評分,mRS≥3分為殘疾,mRS≥3或死亡為複閤結跼。根據入院時總膽紅素、間接膽紅素、直接膽紅素的四分位數水平分彆將研究對象分為4組,採用Cox迴歸分析入院時膽紅素水平與急性缺血性腦卒中患者齣院殘疾、死亡和複閤結跼的關聯。結果髮生殘疾的病例為407例,殘疾髮生率為12.9%,死亡104例,病死率為3.3%。經多因素調整後,髮現以總膽紅素第1分位數組為參比,第4分位數組髮生複閤結跼的aHR值(95%CI)為1.335(1.047~1.702);以間接膽紅素第1分位數組為參比,第4分位數組髮生複閤結跼的aHR值(95%CI)為1.355(1.062~1.728);以直接膽紅素第1分位數組為參比,第3、4分位數組髮生複閤結跼的aHR值(95%CI)分彆為1.403(1.089~1.807)、1.431(1.118~1.833);併且隨著總膽紅素、間接膽紅素和直接膽紅素水平的升高,齣院複閤結跼的髮生風險也在增加(P<0.05)。結論入院時膽紅素水平的升高可增加急性缺血性腦卒中患者齣院複閤結跼的風險、併且存在著劑量反應關繫,是獨立的危險因素。
목적:탐토입원시담홍소수평여급성결혈성뇌졸중환자출원복합결국(잔질혹사망)적관련。방법채용회고성대렬연구적방법,련속성납입2009년6월1일지2012년5월31일부신시중심의원신경내과3151례주원적급성결혈성뇌졸중환자,수집인구통계학、생활방식、림상표현화실험실검험자료。출원시응용개량Rankin량표(modified Rankin scale,mRS)평분,mRS≥3분위잔질,mRS≥3혹사망위복합결국。근거입원시총담홍소、간접담홍소、직접담홍소적사분위수수평분별장연구대상분위4조,채용Cox회귀분석입원시담홍소수평여급성결혈성뇌졸중환자출원잔질、사망화복합결국적관련。결과발생잔질적병례위407례,잔질발생솔위12.9%,사망104례,병사솔위3.3%。경다인소조정후,발현이총담홍소제1분위수조위삼비,제4분위수조발생복합결국적aHR치(95%CI)위1.335(1.047~1.702);이간접담홍소제1분위수조위삼비,제4분위수조발생복합결국적aHR치(95%CI)위1.355(1.062~1.728);이직접담홍소제1분위수조위삼비,제3、4분위수조발생복합결국적aHR치(95%CI)분별위1.403(1.089~1.807)、1.431(1.118~1.833);병차수착총담홍소、간접담홍소화직접담홍소수평적승고,출원복합결국적발생풍험야재증가(P<0.05)。결론입원시담홍소수평적승고가증가급성결혈성뇌졸중환자출원복합결국적풍험、병차존재착제량반응관계,시독립적위험인소。
Objective To explore the association of serum bilirubin level at the time of admission with the compos?ite outcome(disability or death)in discharged patients with acute ischemic stroke. Methods In a retrospective cohortstudy from June 1st 2009 to May 31st 2012, we continuously included 3151 patients with acute ischemic stroke and col?lected demography,lifestyle,clinical manifestations and laboratory test data. Functional outcome was measured with themodified Rankin scale (mRS) when subjects were discharged. Disability was defined as mRS≥3 and composite outcomewas defined as mRS≥3 or death. Serum bilirubin was divided into four groups according to the quartile. Multiple Coxregression analysis was used to assess the independent relation between serum bilirubin and disability death and the com?posite outcome. Results There were 407 disabled patients,the disability rate was 12.9%;and 104 patients were dead,the fatality rate was 3.3%.After adjusting for multiple factors, we found the risks of composite outcome with total bilirubin in the four quartile were higher than that in the first quartile, aHR and 95%CI were 1.335(1.047~1.702) respectively;The risks of composite outcome with indirect bilirubin in the four quartile were higher than that in the first quartile, aHR and 95%CI were 1.355(1.062~1.728) respectively; The risks of composite outcome with bilirubin direct in the third and the forth quartile were higher than that in the first quartile, aHR and 95% CI were11.403(1.089~1.807)and 1.431 (1.118~1.833) respectively.With the increase of total bilirubin,indirect bilirubin and direct bilirubin level,the compos?ite outcome of discharged patient was on the increase. Conclusions The study indicated that higher serum bilirubincould increase the risk of composite outcome in ischemic stroke patients, there was dose-response relationship ,and bili?rubin was a independent risk factor.